Novel oxazolidinone calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraine.
第一作者:
Brendan M,Crowley
第一单位:
Department of Medicinal Chemistry, Merck & Co., Inc., PO Box 4, WP14-2, 770 Sumneytown Pike, West Point, PA 19486, USA. Electronic address: brendan_crowley@merck.com.
作者:
医学主题词
动物(Animals);剂量效应关系, 药物(Dose-Response Relationship, Drug);人类(Humans);偏头痛(Migraine Disorders);分子结构(Molecular Structure);恶唑烷酮类(Oxazolidinones);大鼠(Rats);构效关系(Structure-Activity Relationship)
DOI
10.1016/j.bmcl.2015.07.021
PMID
26231160
发布时间
2018-12-02
- 浏览11
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



